DRES-07. TMZ-LEV- IFN COCKTAIL REGIMEN SIGNIFICANTLY INHIBITED THE GROWTH OF GLIOMA IN VIVO

OBJECTIVE: Temozolomide (TMZ), is the first line chemotherapeutic drug for glioma. Previous studies have suggested that interferon (IFN) and levetiracetam (LEV) could respectively reverse the resistance of TMZ by down-regulating MGMT expression. This study, we aim to investigate the therapeutic effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ni, Xiang-rong, Wang, Jing, Chen, Fu-rong, Cai, Hai-ping, Yu, Yan-jiao, Yang, Qun-ying, Guo, Chengcheng, Chen, Zhong-ping, Qu, Yue
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Drug Resistance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847639/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.295
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados